ELVN insider trading
Enliven Therapeutics, Inc.
In the past 36 days, 3 insiders sold $1.2M.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
J. Scott Garland Director |
$607K 13,000 sh @ $46.67 |
−100.0% | Not pre-scheduled | Oct 1, 2026 Filed Oct 5, 2026 |
Benjamin Hohl CHIEF FINANCIAL OFFICER |
$303K 6,018 sh @ $50.35 |
−13.7% | Pre-scheduled | Sep 17, 2026 Filed Sep 21, 2026 |
Helen Louise Collins CHIEF MEDICAL OFFICER |
$252K 5,000 sh @ $50.35 |
−16.7% | Pre-scheduled | Sep 17, 2026 Filed Sep 21, 2026 |